SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Infinity Pharmaceuticals, Inc. and MedImmune, Inc. Present Updated Phase I Results of IPI-504 in GIST at American Society of Clinical Oncology Annual Meeting